Cardiolite (Lantheus Medical Imaging, Inc.)
Welcome to the PulseAid listing for the Cardiolite drug offered from Lantheus Medical Imaging, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lantheus Medical Imaging, Inc. |
| NON-PROPRIETARY NAME: | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| SUBSTANCE NAME: | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1990-12-20 |
| END MARKETING DATE: | 0000-00-00 |
Cardiolite HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cardiolite from Lantheus Medical Imaging, Inc. |
| LABELER NAME: | Lantheus Medical Imaging, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 1990-12-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 11994-001_d554bad8-499f-45ee-9efd-ea28adc946b2 |
| PRODUCT NDC: | 11994-001 |
| APPLICATION NUMBER: | NDA019785 |
Other TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE Pharmaceutical Manufacturers / Labelers:
